The preoperative management of patients with Parkinson's disease (PD) requires meticulous planning and a thorough understanding of the disease’s progression, associated symptoms, and the patient’s pharmacological regimen. Given the complexity of PD and the risks associated with both the disease and its treatments, a detailed pre-anesthetic check-up is critical. This check-up should focus on several key aspects:
Disease Diagnosis and Duration
The first step in managing a Parkinson’s disease patient preoperatively is to establish a comprehensive understanding of the patient's diagnosis and the duration of their disease. Parkinson’s disease typically presents with three primary symptoms: rest tremor, rigidity, and bradykinesia. A confident diagnosis can be made if the patient exhibits at least two of these cardinal signs. Longer disease duration is often associated with more severe symptoms and greater complications, which may affect the anesthetic plan. Furthermore, disease duration also impacts the likelihood of medication-related complications such as the "wearing-off" and "on-off" effects of levodopa therapy.
Assessment of Comorbidities
Parkinson’s disease predominantly affects older adults, many of whom present with comorbidities typically associated with aging, such as cardiovascular diseases, respiratory dysfunction, and metabolic disorders. These associated conditions must be carefully evaluated to ensure a safe surgical and anesthetic course. Specific attention should be given to autonomic dysfunction, which is common in PD patients and can lead to orthostatic hypotension, sialorrhea, constipation, urinary incontinence, excessive sweating, and seborrhea. Autonomic instability may also cause unpredictable responses to central neuraxial blocks, such as spinal or epidural anesthesia, making general anesthesia a more viable option in many cases.
Respiratory and Gastrointestinal Assessment
Respiratory dysfunction is common in Parkinson’s disease patients due to uncoordinated involuntary muscle movements, muscle rigidity, and pharyngeal muscle weakness. This can lead to difficulties with clearing respiratory secretions, increasing the risk of perioperative aspiration pneumonia. Additionally, gastrointestinal symptoms such as nausea, vomiting, and gastroesophageal reflux are common, partly due to medications or the progression of the disease. Patients may also suffer from delayed gastric emptying, making preoperative acid aspiration prophylaxis a crucial component of management to reduce the risk of aspiration during induction of anesthesia.
Neuropsychiatric Evaluation
Patients with Parkinson’s disease often experience neuropsychiatric symptoms, including mood changes (such as depression), cognitive decline, hallucinations, and psychotic symptoms. These symptoms can be exacerbated in the perioperative period and may lead to postoperative emergence reactions. The rigidity and tremors characteristic of PD may further complicate postoperative care, particularly during extubation, as these symptoms can create challenges for airway management. Therefore, careful preoperative evaluation of the patient’s cognitive and psychiatric status is vital to prevent complications during the postoperative phase.
Medication Management
Preoperative management must include a detailed assessment of the anti-Parkinsonian medications the patient is taking, as well as any potential interactions with anesthetic drugs. The timing of medication doses is especially important, as the abrupt withdrawal of drugs like levodopa can result in a rapid and severe return of symptoms or even the development of neuroleptic malignant syndrome (NMS), a life-threatening condition. Levodopa, which has a short half-life of 1–3 hours, should be continued as close to the time of surgery as possible, often with sips of water on the morning of surgery. For prolonged surgeries or instances where gastric emptying is delayed, administration of levodopa via a duodenal feeding tube may be necessary to maintain stable drug levels.
Patients may also be on other PD medications, such as dopamine agonists (e.g., bromocriptine or lisuride) or monoamine oxidase inhibitors (MAOIs). These drugs can cause hypotension or lead to dangerous drug interactions. For example, MAOIs inhibit the metabolism of narcotics, and care must be taken to avoid interactions that could result in serotonin syndrome. As such, drugs like meperidine should be avoided. It is essential to review all medications the patient is taking to anticipate and mitigate potential perioperative interactions.
Levodopa treatment can result in both “wearing-off” and “on-off” phenomena in long-term patients, where the effectiveness of the drug fluctuates, resulting in sudden rigidity or akinesia. This is particularly relevant intraoperatively, as patients may experience exacerbations of symptoms if their medication regimen is not carefully managed. The timing and dosage of levodopa must be adjusted to prevent the return of symptoms during surgery. Some patients may self-administer additional doses of levodopa, so it is crucial to obtain an accurate medication history to ensure proper intraoperative drug management.
Special Considerations for the Anesthetic Plan
Patients with PD are often at risk for dehydration and hypovolemia due to age-related factors, depression, or the nausea and vomiting associated with both PD and levodopa therapy. These patients may also exhibit significant orthostatic hypotension. As such, adequate fluid management is necessary in the perioperative period to maintain hemodynamic stability and prevent hypotensive episodes during anesthesia. Moreover, dopamine agonists and older antidepressants, such as tricyclic antidepressants, may further exacerbate hypotension, necessitating cautious administration of anesthetic agents that may contribute to vasodilation.
The combination of anti-Parkinsonian drugs and anesthetic agents presents a unique challenge. Levodopa can increase the risk of arrhythmias when used in conjunction with volatile anesthetics such as halothane. This makes it essential to choose anesthetic agents carefully. Similarly, the use of MAO inhibitors increases the risk of hypertensive crises when combined with sympathomimetics, further complicating anesthetic drug selection. Close monitoring of cardiovascular status and careful titration of anesthetic agents are key to managing these risks.
